Skip to main content
Equibles
PFE logo

PFE · Pfizer Inc · Earnings Call Transcripts & Audio

Track PFE — free

Use PFE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PFE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.47 -0.05 (-0.18%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$163.41B
Shares
5.70B
Volume · Sep 30 33.64M Avg daily vol (3M) 37.36M

Pfizer Inc Earnings Call Transcripts

Quarterly earnings calls for Pfizer Inc (PFE), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼5.8% $22.64B $8.61B '22 Q3 22-11-01 ▲5.4% $25.13B $4.99B '22 Q4 23-01-31 ▼28% $18.49B $5.54B '23 Q1 23-05-02 ▼53.1% $13.01B $2.33B '23 Q2 23-08-01 ▼40.4% $13.49B −$2.38B '23 Q3 23-10-16 ▼42% $14.57B −$3.37B '23 Q4 24-01-30 ▼19.5% $14.88B $3.12B '24 Q1 24-05-01 ▲2.1% $13.28B $41.00M '24 Q2 24-07-30 ▲31.2% $17.70B $4.46B '24 Q3 24-12-18 ▲21.9% $17.76B $410.00M '24 Q4 25-02-04 ▼7.8% $13.71B $2.97B '25 Q1 25-04-29 ▲10.3% $14.65B $2.91B '25 Q2 25-08-05 ▼5.9% $16.65B $3.54B '25 Q3 25-12-16 ▼1.2% $17.56B −$1.65B '25 Q4 26-02-03 ▲5.4% $14.45B $2.69B '26 Q1 26-05-05 LATEST ▲2.6% $15.03B −$248.00M '26 Q2 26-08-04
Conference
Investor event
2026-09-22
Pfizer Inc (PFE) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-14
Pfizer Inc (PFE) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
Pfizer Inc (PFE) Q2 2026 Earnings Call Transcript
Confident tone COVID-19 franchise variability Oncology portfolio (PADCEV, mephrometastat, 4404) Obesity/GLP-1 (berobenadide)
Revenue
$15.03B
▲ 2.6% YoY
Diluted EPS
$-0.04
▼ 107.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Pfizer Inc (PFE) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Pfizer Inc (PFE) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Pfizer Inc (PFE) Q1 2026 Earnings Call Transcript
Confident tone Obesity / Metsera Acquisition Oncology Pipeline & Seagen Capital Allocation & Dividend
Revenue
$14.45B
▲ 5.4% YoY
Diluted EPS
$0.47
▼ 9.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-03
Pfizer Inc (PFE) Q4 2025 Earnings Call Transcript
Confident tone Obesity / Metsera pipeline AI scaling across the enterprise R&D catalysts and pipeline milestones
Revenue
$17.56B*
▼ 1.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-12-16
Pfizer Inc (PFE) Q3 2025 Earnings Call Transcript
Confident tone Late-stage pipeline catalysts and upcoming data Metsera acquisition and competitive dispute R&D pipeline and oncology assets
Revenue
$16.65B
▼ 5.9% YoY
Diluted EPS
$0.62
▼ 20.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Pfizer Inc (PFE) Q2 2025 Earnings Call Transcript
Confident tone Capital allocation and business development Vaccine portfolio Full-year 2025 guidance raise
Revenue
$14.65B
▲ 10.3% YoY
Diluted EPS
$0.51
▲ 5000% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Pfizer Inc (PFE) Q1 2025 Earnings Call Transcript
Positive tone Capital allocation and dividend Q1 financial results and 2025 guidance Loss of exclusivity (LOE) planning
Revenue
$13.71B
▼ 7.8% YoY
Diluted EPS
$0.52
▼ 5.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-04
Pfizer Inc (PFE) Q4 2024 Earnings Call Transcript
Positive tone R&D pipeline progress Business development strategy Oncology franchise strength
Revenue
$17.76B*
▲ 21.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-12-18
Pfizer Inc (PFE) Q3 2024 Earnings Call Transcript
Confident tone Pipeline advancement Obesity / oral GLP-1 Seagen integration
Revenue
$17.70B
▲ 31.2% YoY
Diluted EPS
$0.78
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Pfizer Inc (PFE) Q2 2024 Earnings Call Transcript
Confident tone Oncology leadership and Seagen integration VYNDAQEL growth and upcoming IP loss Obesity pipeline (danuglipron)
Revenue
$13.28B
▲ 2.1% YoY
Diluted EPS
$0.01
▼ 97.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript
Positive tone Oncology leadership and Seagen integration RSV vaccine ABRYSVO expansion VYNDAQEL patent and exclusivity
Revenue
$14.88B
▼ 19.5% YoY
Diluted EPS
$0.55
▼ 43.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-30
Pfizer Inc (PFE) Q4 2023 Earnings Call Transcript
Positive tone Oncology leadership and Seagen integration Pipeline innovation and R&D Vaccines - pneumococcal and flu/COVID combination
Revenue
$14.57B*
▼ 42% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-16
Pfizer Inc (PFE) Q3 2023 Earnings Call Transcript
Revenue
$13.49B
▼ 40.4% YoY
Diluted EPS
$-0.42
▼ 127.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Pfizer Inc (PFE) Q2 2023 Earnings Call Transcript
Revenue
$13.01B
▼ 53.1% YoY
Diluted EPS
$0.41
▼ 76.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Pfizer Inc (PFE) Q1 2023 Earnings Call Transcript
Revenue
$18.49B
▼ 28% YoY
Diluted EPS
$0.97
▼ 29.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-31
Pfizer Inc (PFE) Q4 2022 Earnings Call Transcript
Revenue
$25.13B*
▲ 5.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Pfizer Inc (PFE) Q3 2022 Earnings Call Transcript
Revenue
$22.64B
▼ 5.8% YoY
Diluted EPS
$1.51
▲ 6.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Pfizer Inc (PFE) Q2 2022 Earnings Call Transcript
Revenue
$27.74B
▲ 46.8% YoY
Diluted EPS
$1.73
▲ 76.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Pfizer Inc (PFE) Q1 2022 Earnings Call Transcript
Revenue
$25.66B
▲ 76.8% YoY
Diluted EPS
$1.37
▲ 59.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-08
Pfizer Inc (PFE) Q4 2021 Earnings Call Transcript
Revenue
$23.84B*
▲ 108.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Pfizer Inc (PFE) Q3 2021 Earnings Call Transcript
Revenue
$24.04B
▲ 133.9% YoY
Diluted EPS
$1.42
▲ 446.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Pfizer Inc (PFE) Q2 2021 Earnings Call Transcript
Revenue
$18.90B
▲ 91.6% YoY
Diluted EPS
$0.98
▲ 58.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Pfizer Inc (PFE) Q1 2021 Earnings Call Transcript
Revenue
$14.52B
▲ 44% YoY
Diluted EPS
$0.86
▲ 43.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-02
Pfizer Inc (PFE) Q4 2020 Earnings Call Transcript
Revenue
$11.43B*
▲ 520% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Pfizer Inc (PFE) Q3 2020 Earnings Call Transcript
Revenue
$10.28B
▼ 19% YoY
Diluted EPS
$0.26
▼ 79.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Pfizer Inc (PFE) Q2 2020 Earnings Call Transcript
Revenue
$9.86B
▼ 25.6% YoY
Diluted EPS
$0.62
▼ 26.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Pfizer Inc (PFE) Q1 2020 Earnings Call Transcript
Revenue
$10.08B
▼ 23.1% YoY
Diluted EPS
$0.60
▼ 7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-28
Pfizer Inc (PFE) Q4 2019 Earnings Call
Revenue
$1.84B*
▲ 59.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–31 of 31 earnings calls
Key facts CIK 78003 CUSIP 717081103 13F (30d) 85 filings 33 filers Visit website Investor relations